Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
5 hedge funds and large institutions have $725K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
2.84% less ownership
Funds ownership: 11.34% → 8.5% (-2.8%)
17% less funds holding
Funds holding: 6 → 5 (-1)
48% less capital invested
Capital invested by funds: $1.39M → $725K (-$667K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
+$54.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$53.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.24K |
| 4 |
Morgan Stanley
New York
|
+$394 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$336K |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
-$72.4K |
| 3 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$14 |
PILL Hedge Fund Activity: Q2 2025 in Review
5 institutional investors reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2025, worth a combined $725K — down 48% from $1.39M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PILL and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.
The largest buyer was GTS Securities, opening a new position worth an estimated $54.5K. The largest seller was Tower Research Capital (TRC), cutting an estimated $336K.
- 5 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2025, down from 6 in Q1 2025.
- Funds reported $725K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2025, down 48% quarter-over-quarter.
- 1 fund opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2025 and 2 closed out, a net change of -1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2025 was GTS Securities, an estimated $54.5K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q2 2025 was Tower Research Capital (TRC), an estimated $336K sold.
Based on aggregated 13F filings for Q2 2025.